Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Barclays PLC Major Shareholding Notification 2021

Feb 22, 2021

5250_rns_2021-02-22_f923b0b0-8139-45ad-9a0c-a8974598e62e.html

Major Shareholding Notification

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

Form 8.3 - WILLIS TOWERS WATSON PLC AMENDMENT

FORM 8.3 Amendment to Purchases

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 17 February 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
2,067,208 1.60% 490,088 0.38%
(2) Derivatives (other than options):
183,127 0.14% 278,405 0.22%
(3) Options and agreements to
purchase/sell: 6,000 0.00% 6,000 0.00%
TOTAL:
2,256,335 1.75% 774,493 0.60%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale Number of relevant securities Price per unit
Purchase 2 228.6750 USD
Purchase 4 228.1200 USD
Purchase 7 227.9900 USD
Purchase 11 229.8800 USD
Purchase 34 227.9792 USD
Purchase 100 229.3000 USD
Purchase 100 227.6400 USD
Purchase 258 229.4802 USD
Purchase 403 228.6482 USD
Purchase 895 229.1759 USD
Purchase 3,274 228.2158 USD
Purchase 4,249 228.3696 USD
Purchase 13,883 229.2683 USD
Purchase 14,019 229.8900 USD
Purchase 40,306 228.4178 USD
Sale 2 228.6750 USD
Sale 4 227.8700 USD
Sale 11 229.8800 USD
Sale 12 228.0445 USD
Sale 47 228.5163 USD
Sale 63 230.1500 USD
Sale 108 229.2125 USD
Sale 140 229.1321 USD
Sale 173 228.2961 USD
Sale 188 228.2177 USD
Sale 200 228.3850 USD
Sale 224 229.5724 USD
Sale 380 228.4984 USD
Sale 540 228.6555 USD
Sale 625 228.5794 USD
Sale 749 228.6303 USD
Sale 760 228.0326 USD
Sale 791 229.5260 USD
Sale 895 229.1759 USD
Sale 1,060 228.5012 USD
Sale 1,122 228.1154 USD
Sale 1,345 228.3168 USD
Sale 1,367 228.5530 USD
Sale 1,433 228.3502 USD
Sale 1,500 229.8681 USD
Sale 1,883 228.4494 USD
Sale 2,171 229.8838 USD
Sale 3,673 228.2181 USD
Sale 3,885 228.2728 USD
Sale 4,076 228.3728 USD
Sale 5,322 229.8900 USD
Sale 5,519 229.8859 USD
Sale 7,942 228.2058 USD
Sale 9,393 229.3495 USD
Sale 18,916 228.5392 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD
Nature of transaction

(Note 6)
Number of relevant securities

(Note 7)
Price per unit

(Note 5)

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option
Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)

(ii) Exercising

Product name,

e.g. call option
Number of securities Exercise price per unit (Note 5)

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)
Details Price per unit

(if applicable) (Note 5)

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing
and any other person relating to the voting rights of any relevant securities under any option
referred to on this form or relating to the voting rights or future acquisition or disposal of any
relevant securities to which any derivative referred to on this form is referenced. If none, this
should be stated.
NONE

Is a Supplemental Form 8 attached? (Note 9) YES/NO

Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 22 Feb 2021
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates
Call Options Purchased 6,000 220.0000 American Jul 16, 2021
Put Options Purchased -6,000 200.0000 American Jul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210222005385/en/

BARCLAYS PLC